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Abstract: A chemical investigation on the cultures of Xylaria carpophila led to the isolation of one known cyclopeptide cyclo(N-
methyl-L-Phe-L-Pro-L-Leu-D-Ile-L-Val) (1), five new sesquiterpenes, named as xylcarpins AE (26), and another known compound 
(7). The structures were determined by extensive NMR and MS spectroscopic analysis. The absolute configuration of 1 was estab-
lished by use of Marfey’s method and ROESY spectroscopic data. All compounds were tested for their cytotoxicities against five 
human cancer cell lines. Compound 7 showed week inhibitory activity. 
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Introduction 
Fungi of the genus Xylaria are known to produce many 
types of bioactive compounds. Previous studies revealed that 
isopimarane diterpene glycosides,1 xylopimarane,2 
4,6,8(14),22-tetraen-3-one,3 xylarisin,4 coloratin A,5 
kolokoside A,6 cytochalasins,7 clonostachydiol,7 xylobovide,7 
07H239-A,8 cytochalasin D,9 multiplolides A and B,10 
sordaricin,11 mellisol,12 1,8-dihydroxynaphthol 1-O-α-
glucopyranoside,12 benzoquinones,13 and integric acid14 from 
some species of this genus showed diverse pharmacological 
properties, including cytotoxic, antimicrobial, antifungal, 
anthelmintic, antivirus, and antimalarial activities. But the 
chemical constituents of Xylaria carpophila have received 
little attention. Our current investigation on the cultures of X. 
carpophila led to the isolation of one known cyclopeptide, 
cyclo(N-methyl-L-Phe-L-Pro-L-Leu-D-Ile-L-Val) (1), five new 
sesquiterpenes, named as xylcarpins A–E (2–6), and one 
known compound (7). The structures of cyclo(N-methyl-L-
Phe-L-Pro-L-Leu-D-Ile-L-Val) (1), and xylcarpins A–E (2–6) 
were elucidated by means of spectroscopic methods. The 
known compound (7) was identified as (4S,5S,6S)-5,6-epoxy-
4-hydroxy-3-methoxy-5-methyl-cyclohex-2-en-1-one15 by 
comparison with data in the literature. All of these compounds 
were tested for their cytotoxicities against five human cancer 
cell lines. 
 
Results and Discussion 
Compound 1 was obtained as a white powder. The 
molecular formula was established as C32H49N5O5 on the basis 
of its HRESIMS at m/z 584.3802 [M + H]+ (calcd for 
C32H50N5O5, 584.3811) indicating 11 degrees of unsaturation. 
The IR absorption bands at 3292, 1642 cm−1 indicated the 
presence of NH and CO groups. The 1D NMR spectroscopic 
data (Table 1) revealed the presence of three NH protons (δH 
9.76, 9.29, and 7.70, respectively), six methyl groups as well 
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as one amide N-CH3 signal (δH 3.47; δc 31.6), six methylene 
signals, eight sp3 methine signals, a monosubstituted benzene 
ring signals, and five carbonyl carbons. Preliminary analysis 
of these NMR and MS data suggested that compound 1 might 
be a pentapeptide. In the 1H-1H COSY spectrum (Figure 1), six 
fragments were established indicating that compound 1 
comprised one leucine, one isoleucine, one valine, one proline 
and one phenylalanine. The HMBC correlation of δH 3.47 (3H, 
s, Me-N) with δC 58.2 (CH, α-carbon of the phenylalanine) 
suggested the methyl substitution at N-atom of phenylalane. In 
addition, the HMBC correlations also established the amino 
acids sequence to be N-methyl-Phe-Pro-Leu-Ile-Val (Figure 1). 
These data indicated that compound 1 was structurally the 
same as cyclo(N-methyl-L-Phe-L-Val-D-Ile-L-Leu-L-Pro).16 
Advanced Marfey’s method was applied to identify the 
configuration of the amino acid, and showed the presence of 
L-Leu as well as L-Val. The configurations of N-MePhe1, Pro2, 
Leu3, Ile4 and Val5 were determined to be L, L, L, D, L 
respectively by the application of the Marfey’s method, the 
analysis of ROESY correlations (Table 1 and Figure 1) and 
the comparison with the data of cyclo(N-methyl-L-Phe-L-Pro-L-
Leu-D-Ile-L-Val).16 
Compound 2 was purified as a white powder. The molecular 
formula was determined as C15H24O2 by HRESIMS at m/z 
259.1671 [M + Na]+ (calcd for C15H24O2Na, 259.1673), with 
four degrees of unsaturation. The IR spectrum indicated the 
presence of hydroxy (3441 cm−1) and carbonyl (1706 cm−1) 
 
 
Figure 1.  Key 2D NMR correlations for 1. 
Table 1. NMR data of 1 in pyridine-d5. 
amino acid position δC (multi) δH (J in Hz)  HMBC ROESY 
N-methyl Phe CO 172.0, qC  α, NH-Val  
 α 58.2, CH 5.49, m β, γ, N-CH3 β, NHVal, αVal 
 β 36.0, CH2 3.23, dd (14.2, 9.1); 3.37, dd (14.2, 7.7) α, ortho, γ α, ortho 
 γ 138.3, qC  meta  
 ortho 129.8, CH 7.23, m meta, para α, β, βPro 
 meta 129.3, CH 7.28, m para γPro, β 
 para 127.0, CH 7.25, m ortho  
 N-CH3 31.6 3.47, s α αPro, βPro 
Pro CO 173.4, qC  α, β, N-Me-Phe  
 α 60.3, CH 5.59, m β, γ β, N-Me, αLeu3, 
 β 31.5, CH2 1.45, m; 2.03, m γ, δ γ 
 γ 21.9, CH2 1.66, m β β, δ 
 δ 47.0, CH2 3.73, m; 3.82, m β, γ γ 
Leu CO 170.2, qC  α  
 α 48.5, CH 5.40, m β, γ β, αPro 
 β 42.7, CH2 1.96, m α, γ, δ α 
 γ 25.7, CH 1.79, m α, β, δ α, β 
 δ 23.6, CH3; 23.2, CH3 0.95, d (6.6); 0.99, d (6.4) β, γ  
 NH  9.76, d (9.3) α α, β, αLeu3 
Ile CO 172.2, qC  α, NH-L-Leu  
 α 57.4, CH 4.90, m β, δ, γ β, γ, NHLeu3 
 β 39.6, CH 1.99, m α, δ, γ α 
 γ 27.5, CH2 1.29, m; 1.67, m δ α 
 β-CH3 12.4,  CH3 0.90, t (7.4)   
 δ 15.3, CH3 1.05, d (6.8)   
 NH  7.70, d (8.7) α,  α, αVal,  
Val CO 172.6, qC  α, NH-D-Leu  
 α 59.4, CH 4.56, t (10.1) β, γ β, NH, αN-MePhe, NHLeu4 
 β 27.7, CH 2.27, m α, γ α 
 γ 19.4, CH3; 20.8, CH3 0.86, d (6.9); 1.03, d (6.6)   
 NH  9.29, d (9.7) α α, β, αN-MePhe 
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groups. The 1H NMR spectrum (Table 2) showed signals for 
an oxymethine proton at δH 3.41, three singlet methyl signals 
(δH 0.76, 1.09, 1.15) and one doublet methyl signal (δH 1.16, J 
= 8.0 Hz). The 13C NMR and DEPT spectra (Table 2) showed 
15 carbon resonances ascribable for four methyls, four 
methylenes, three methines (including one oxygen-bearing 
methine), and four quaternary carbons (one of which is a 
carbonyl carbon). Apart from one degree of unsaturation 
occupied by one carbonyl group, the remaining three degrees 
of unsaturation indicated that compound 2 should possess a 
three-ring system including one three-membered carbon ring 
according to the typical methylene signal at δC 6.2. In the 1H-
1H COSY spectrum, two fragments was established as shown 
with bold line in Figure 2. These data suggested that 
compound 2 possessed a backbone related to the known 
compound thujopsene.17 The major differences including a 
hydroxy group at C-3 (δC 78.4) and a carbonyl group at C-2 
(δC 214.5) were established by the HMBC and 1H-1H COSY 
spectra analysis (Figure 2). The relative configuration of 2 was 
elucidated by the ROESY experiment (Figure 2). The ROESY 
correlations of H-13 with H-7 and H-10, and H-10 with H-1 
implied that OH-7, CH3-14, three-membered ring and CH3-11 
to be the same side. ROESY correlations of Ha-3 (δH 2.13) 
with Hb-12 (0.49) and H-15 suggested that the CH3-15 was at 
the same side with the three-membered ring. Therefore, the 
structure of 2 was established and named as xylcarpin A. 
Compound 3 was isolated as a white powder with a 
molecular formula of C15H24O based on the positive ion 
HRESIMS at m/z 203.1800 [M − OH]+ (calcd for C15H23, 
203.1799). The NMR data (Table 2) were similar to those of 2 
with the major differences being that the signal of the carbonyl 
carbon at C-2 was absent, showing instead a pair of double 
bond functionality between C-1 (δC 135.5) and C-2 (δC 114.6), 
which was supported by the HMBC correlations from δH 1.80 
(3H, s, H-11) to δC 135.5 (s, C-1) and from δH 1.76 (1H, m, H-
3) to δC 114.6 (d, C-2). The same ROESY correlations of 3 
and 2 indicated their identical relative configuration. Therefore, 
compound 3 was established and named as xylcarpin B. 
Compound 4 was obtained as a white powder. The IR 
spectrum showed the existence of hydroxy groups (3417 cm−1). 
The NMR data were quite similar to those of 3, except for the 
methyl at C-11 was oxygenated into a methylene (δC 67.1), 
which was supported by the HMBC correlation of δH 4.13 (2H, 
d, J = 4.8 Hz, H-11) with δC 139.3 (s, C-1). Furthermore, the 
same ROESY data of 3 and 4 suggested the same relative 
configuration of them. Therefore, compound 4 was established 
as depicted, and named as xylcarpin C. 
Compound 5 was isolated as a colorless oil with the 
molecular formula of C15H26O3 based on the HRESIMS at m/z 
277.1773 [M + Na]+ (calcd for C15H26O3Na, 277.1779). IR 
absorption bands at 3424 cm-1 indicated the presence of 
hydroxy groups. The 13C NMR spectrum (Table 3) showed 15 
carbons including one trisubstituded double-bond resonance at 
δC 134.6 and 125.5 and four oxygenated carbons at δC 86.3, 
84.6, 70.6 and 68.8. Four methyl signals at δC 28.0, 24.2, 24.1 
and 21.1 were also observed. Except for the location of one 
hydroxy group , the NMR spectroscopic data features of 5 
 
 
Figure 2.  Key 2D NMR correlations for 2.
Table 2. 1H and 13C NMR data of 24 in CDCl3. 
 
Entry 
2 3 4 
δH (J in Hz) δC mult. δH (J in Hz) δC mult. δH (J in Hz) δC mult. 
1 2.61, m 40.2, CH  135.5, qC  139.3, qC 
2  214.5, qC 5.02 br. d (6.4) 114.6, CH 5.30 br. d (6.1) 116.5, CH 
3 2.13, d (16.8); 1.77, d (16.8) 52.3, CH2 1.76, m; 1.44, m 40.8, CH2 1.83, m; 1.54, m 40.3, CH2 
4  37.6, qC  31.3, qC  31.6, qC 
5 1.45, m 36.6, CH2 1.54, m 
1.15, m 
34.5, CH2 1.51, m 
1.18, m 
34.4, CH2 
6 1.79, m  28.2, CH2 1.72, m 
1.78, m 
28.6, CH2 1.80, m 
1.73, m 
28.5, CH2 
7 3.41, ddd (10.8, 5.3, 5.3) 78.4, CH 3.34, ddd (11.5, 5.6, 5.2) 78.5, CH 3.34, ddd (11.7, 5.4, 5.2) 78.4, CH 
8  39.5, qC  39.5, qC  39.5, qC 
9  32.5, qC  34.8, qC  34.5, qC 
10 1.34, m  23.0, CH 1.24, m 22.1, CH 1.44, m 18.8, CH 
11 1.16, d (8.0) 17.2, CH3 1.80, s 23.6, CH3 4.13, d (4.8) 67.1, CH2 
12 0.56, m  
0.49, m  
6.2, CH2 0.72, m 
0.71, m 
10.7, CH2 0.79, m 
0.74, m  
10.9, CH2 
13 0.76, s  24.9, CH3 0.75, s 24.3, CH3 0.77, s 24.3, CH3 
14 1.09, s 21.1, CH3 1.09, s 19.3, CH3 1.10, s 20.9, CH3 
15 1.15, s 28.3, CH3 1.12, s 28.6, CH3 1.15, s 28.6, CH3 
7-OH 1.40, d (5.3)  1.30, d (5.6)  1.33, d (5.2)  
11-OH     1.34, t (4.8)  
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were quite similar to those of (1R)-1-hydroxybisabololoxide 
B.18 The hydroxy group was attached to C-4 as supported by 
the HMBC correlation from δH 1.77 (3H, s, H-15) to δC 68.8 (d, 
C-4). By comparison of the NMR spectroscopic data and the 
optical rotation data of (1R)-1-hydroxybisabololoxide B,18 the 
relative configurations of C-6, C-7 and C-10 in 5 were 
deduced as same as those in (1R)-1-hydroxybisabololoxide B. 
In the ROESY spectrum, the correlation between H-4 and H-6 
was not observed, indicating that the hydroxy group at C-4 
should be α-oriented, which was also supported by the broad 
singlet of H-4. Compound 5 was established and named as 
xylcarpin D. 
Compound 6 was obtained as colorless oil. The molecular 
formula of C15H26O4 was indicated by the HRESIMS at m/z 
293.1724 [M + Na]+ (calcd for C15H26O4Na, 293.1728). 1D 
NMR data were very similar to those of compound 5 except 
for an oxygenated quaternary carbon at δC 70.0 (s, C-6) in 6 
instead of a methine in 5. Analysis of the HMBC spectrum 
suggested that one hydroxy group was placed at C-6 by the 
correlation of δC 2.30 (1H, m, H-1) and 1.96 (1H, m, H-5) with δC 70.0 (s, C-6). Detailed analysis of other 2D NMR data 
suggested that other parts of 6 were identical to those of 5. 
Therefore, compound 6 was established and named as 
xylcarpin E. 
Compounds 17 were evaluated for their cytotoxicities 
against five hunman cancer cell lines using the MTT method 
as reported previously19. Compound 7 showed week cytotoxi-
city against four of the tested cell lines (Table 4), while other 
compounds were inactive to all tested cell lines (IC50 values of 
more than 40 μM). 
 
Experimental Section 
General Experimental Procedures. Optical rotations (OR) 
were recorded on a Jasco P-1020 digital polarimeter. Infrared 
spectroscopy (IR) spectra were obtained on a Bruker Tensor 
27 FT-IR spectrometer with KBr pellets. Nuclear Magnetic 
Resonance (NMR) spectra were obtained on a Bruker Avance 
III 600 MHz spectrometer with tetramethylsilane (TMS) as an 
internal standard at room temperature. Electrospray ionization-
mass spectra (ESI-MS) and high-resolution (HR) ESI-MS 
were recorded on a VG Autospec-3000 mass spectrometer and 
an API QSTAR Pulsar I spectrometer. Silica gel (200–300 
mesh, Qingdao Marine Chemical Ltd., China) and Sephadex 
LH-20 (Amersham Biosciences, Sweden) were used for open 
column chromatography (CC). MPLC was performed on a 
Büchi Sepacore system (Büchi Labortechnik AG, Switzerland), 
and columns packed with RP-18 silica gel (40–75 μm, Fuji 
Silysia Chemical Ltd., Japan). Preparative HPLC was per-
formed on an Agilent 1100 liquid chromatography system 
equipped with a Zorbax SB-C18 column (9.4 mm × 150 mm). 
Fractions were monitored by TLC. Spots were visualized by 
heating silica gel plates immersed in Vanillin-H2SO4 in ethanol. 
 
Fungal Material and Cultivation Conditions. The fungus 
Xylaria carpophila (Pers.) Fr. was collected from Gaoligong 
Mountains in Yunnan Province, China, in 2008. The fungus 
was identified by Prof. Zhu-Liang Yang at the Kunming Insti-
tute of Botany. A voucher specimen was deposited at the Her-
barium of Kunming Institute of Botany, Chinese Academy of 
Sciences. The culture medium consisted of glucose (5%), pep-
tone from porcine meat (0.15%), yeast powder (0.5%), 
KH2PO4 (0.5%) and MgSO4. Fermentation was carried out on 
a shaker at 160RPM for 25 days. 
 
Extraction and Isolation. The culture broth (21 L) was fil-
tered, and the filtrate was extracted three times with EtOAc 
while the mycelium was extracted three times with CH3Cl-
MeOH (1:1). The EtOAc layer together with the mycelium 
extraction was concentrated under reduced pressure to give a 
crude extract (4.5 g), and this residue was subjected to CC 
over silica gel (200–300 mesh) eluted with a gradient of 
CH3Cl-MeOH (1:0 → 0:1) to obtain eight fractions (1–8). 
Fraction 2 (570 mg) applied to MPLC (MeOH-H2O, eluting 
from 50:50 to 100:0 for 100 mins with a flow of 20 mL/min) 
then isolated and purified by repeated silica gel chromatog-
raphy, eluted with petroleum ether/EtOAc (2:1), followed by 
Sephadex LH-20 (Me2CO) to afford 2 (2.5 mg), 3 (0.7 mg), 5 
(1.4 mg) and 7 (1.0 mg). Compound 1 (6 mg) precipitated 
from fraction 2. Fraction 3 (130 mg) was applied to MPLC 
(MeOH-H2O, eluting from 0:1 to 1:0 for 60 mins with a flow 
rate of 20 mL/min) to give four subfractions (3a-3d). Fraction 
3d was subjected to silica gel, eluted with CH3Cl/Me2CO (10:1) 
to yield compound 4 (3 mg). Fraction 5 was isolated by pre-
parative HPLC (MeCN-H2O, eluting from 0:100 to 50:50 for 




δH (J in Hz) δC mult. δH (J in Hz) δC mult. 
1 2.05, m 
1.76, m 
27.4, CH2 2.30, m 
1.99, m 
34.2, CH2
2 5.55, m 125.5, CH 5.26, br. s 121.1, CH
3  134.6, qC  137.6, qC 
4 4.01, br. s 68.8, CH 4.22, m 68.4, CH 
5 1.98, m 
1.43, m 
33.2, CH2 1.96, m 
1.40, m 
40.0, CH2
6 1.83, m 37.8, CH  70.0, qC 
7  84.6, qC  89.0, qC 
8 1.87, m 
1.61, m 
35.7, CH2 2.31, m 
1.53, m 
33.7, CH2
9 1.83, m 
1.77, m 
26.6, CH2 1.95, m 
1.85, m 
27.2, CH2
10 3.67, dd  
(10.0, 5.5) 
86.3, CH 3.79, dd  
(7.5, 7.4) 
85.6, CH 
11  70.6, qC  71.9, qC 
12 1.18, s 28.0, CH3 1.21, s 28.0, CH3
13 1.09, s 24.2, CH3 1.05, s 26.5, CH3
14 1.12, s 24.1, CH3 1.15, s 23.5, CH3
15 1.77, s 21.1, CH3 1.70, s 19.5, CH3
4-OH   3.58, d (7.1)  
6-OH   3.70, s  
11-OH   3.75, s  
Table 4. Cytotoxicity for 7 (IC50, μM). 
Entry HL-60 SMMC-7721 A-549 MCF-7 SW480
7 23.1 > 40 35.7 28.5 29.0 
cisplatina 1.3 15.4 17.3 15.8 24.4 
apositive control. 
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50 mins followed by 50:50 to 100:0 for 30mins with a flow 
rate of 20 mL/min) to give a mixture, and compound 6 (2 mg) 
was separated from the mixtures by Sephadex LH-20 (Me2CO). 
 
Cyclo(N-methyl-L-Phe-L-Pro-L-Leu-D-Ile-L-Val) (1): 
white powder; [α]22D  − 59.5 (c 0.26, MeOH); IR (KBr) max 
3292, 2960，1642, 1527, 1383, 740, 698 cm−1; 1H (600 MHz) 
and 13C NMR (150 MHz) data (methanol-d4), see Table 1; 
positive ion HRESIMS m/z 584.3802 [M + H]+ (calcd for 
C32H50N5O5, 584.3811). 
 
Xylcarpin A (2): white powder; [α] 22D  + 161.6 (c 0.19, 
Me2CO); IR (KBr) max 3441, 2923, 1706, 1630 cm−1; 1H (600 
MHz) and 13C NMR (150 MHz) data (CDCl3), see Table 2; 
positive ion HRESIMS m/z 259.1671 [M + Na]+ (calcd for 
C15H24O2Na, 259.1673). 
 
Xylcarpin B (3): white powder; [α] 22D  + 12.5 (c 0.11, 
Me2CO); IR (KBr) max 3420, 2958, 2924, 2855, 1630, 1453, 
1066, 1042 cm−1; 1H (600 MHz) and 13C NMR (150 MHz) 
data (CDCl3), see Table 2; positive ion HRESIMS m/z 
203.1800 [M − OH]+ (calcd for C15H23, 203.1799). 
 
Xylcarpin C (4): white powder; [α] 22D  + 86.3 (c 0.10, 
Me2CO); IR (KBr) max 3417, 2937, 2920, 1631, 1456, , 1064, 
1044, 1006 cm−1; 1H (600 MHz) and 13C NMR (150 MHz) 
data (CDCl3), see Table 2; positive ion HRESIMS m/z 
259.1667 [M + Na]+ (calcd for C15H26O2Na, 259.1673). 
 
Xylcarpin D (5): colorless oil; [α]22D − 64.0 (c 0.14, Me2CO); 
IR (KBr) max 3424, 2970, 2933, 2876, 1640, 1452, 1375, 1161, 
1127, 1080, 1058, 1033, 957, 942, 807 cm−1; 1H (600 MHz) 
and 13C NMR (150 MHz) data (CDCl3), see Table 3; positive 
ion HRESIMS m/z 277.1773 [M + Na]+ (calcd for C15H26O3, 
277.1779). 
 
Xylcarpin E (6): colorless oil; [α]22D − 36.6 (c 0.12, Me2CO); 
IR (KBr) max 3430, 2969, 2924, 2854, 1633, 1455, 1378, 1079, 
1057, 1037 cm−1; 1H (600 MHz) and 13C NMR (150 MHz) 
data (CDCl3), see Table 3; positive ion HRESIMS m/z 
293.1724 [M + Na]+ (calcd for C15H26O4Na, 293.1728). 
 
Marfey’s Reaction to Identify the Absolute Configura-
tion of 1. Compound 1 (1.0 mg) was dissolved in 1 mL of 6 N 
HCl and heated at 120°C for 20 h. After that, the hydrolyzate 
must be evaporated to dryness under a stream of N2 to remove 
traces of HCl. The hydrolyzate was added a 1% solution of L-
FDDA (100 μL) in acetone and 1M NaHCO3 (20 μL), and the 
mixture was heated at 40℃ for 45 min. The standard amino 
acid L-Val and D-/L-Leu were treated the same way, and all 
the reactions must be stopped by addition of HCl (2 M; 10 
μL).16,20 When all these sovents were evaporated, The N-
[(dinitrophenyl)-5-L-alanine amide] amino acid derivatives 
were  redissolved in MeCN-H2O (1:1) followed by HPLC 
analysis (Agilent 1100 liquid chromatography system 
equipped with a Zorbax SB-C18 column (4.6 mm × 150 mm); 
solvents: (A) water + 0.05% TFA, (B) MeCN; linear gradient: 
0 min 10%, 40min 50%, 1 mL/min). HPLC analysis of the 
reaction products of the hydrolysate of compound 1 showed 
the presence of both L-Leu as well as L-Val. 
 
Cytotoxicity Assay. Human myeloid leukemia HL-60, 
hepatocellular carcinoma SMMC-7721, lung cancer A-549 
cells, breast cancer MCF-7 and colon cancer SW480 cell lines 
were used in the cytoxic assay. All the cells were cultured in 
RPMI-1640 or DMEM medium (Hyclone, USA), supplement-
ed with 10% fetal bovine serum (Hyclone, USA) in 5% CO2 at 
37 C. The cytotoxicity assay was performed according to the 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide) method in 96-well microplates.19 Briefly, 100 µL 
adherent cells were seeded into each well of 96-well cell cul-
ture plates and allowed to adhere for 12 h before drug addition, 
while suspended cells were seeded just before drug addition 
with initial density of 1 × 105 cells/mL. Each tumor cell line 
was exposed to the test compound dissolved in DMSO at con-
centrations of 0.0625, 0.32, 1.6, 8, and 40 μM in triplicates for 
48 h, with cisplatin (Sigma, USA) as a positive control. After 
compound treatment, cell viability was detected and a cell 
growth curve was graphed. IC50 values were calculated by 
Reed and Muench’s method.21 
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